FOAMIX PHARMACEUTICALS LTD's ticker is FOMX and the CUSIP is M46135105. A total of 69 filers reported holding FOAMIX PHARMACEUTICALS LTD in Q1 2017. The put-call ratio across all filers is 0.15 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2019 | $3,000 | 0.0% | 1,100 | +10.0% | 0.00% | – |
Q3 2019 | $3,000 | -25.0% | 1,000 | -33.3% | 0.00% | – |
Q2 2019 | $4,000 | -33.3% | 1,500 | 0.0% | 0.00% | – |
Q1 2019 | $6,000 | +20.0% | 1,500 | 0.0% | 0.00% | – |
Q4 2018 | $5,000 | -44.4% | 1,500 | 0.0% | 0.00% | – |
Q3 2018 | $9,000 | +80.0% | 1,500 | +50.0% | 0.00% | – |
Q2 2018 | $5,000 | 0.0% | 1,000 | 0.0% | 0.00% | – |
Q1 2018 | $5,000 | -16.7% | 1,000 | 0.0% | 0.00% | – |
Q4 2017 | $6,000 | -95.1% | 1,000 | -95.5% | 0.00% | -100.0% |
Q3 2017 | $122,000 | +14.0% | 22,000 | -4.3% | 0.00% | 0.0% |
Q2 2017 | $107,000 | +2040.0% | 23,000 | +2200.0% | 0.00% | – |
Q1 2017 | $5,000 | -54.5% | 1,000 | 0.0% | 0.00% | – |
Q4 2016 | $11,000 | +22.2% | 1,000 | 0.0% | 0.00% | – |
Q3 2016 | $9,000 | +50.0% | 1,000 | 0.0% | 0.00% | – |
Q2 2016 | $6,000 | -14.3% | 1,000 | 0.0% | 0.00% | – |
Q1 2016 | $7,000 | -12.5% | 1,000 | 0.0% | 0.00% | – |
Q4 2015 | $8,000 | -27.3% | 1,000 | -33.3% | 0.00% | – |
Q3 2015 | $11,000 | +37.5% | 1,500 | +100.0% | 0.00% | – |
Q2 2015 | $8,000 | +60.0% | 750 | +50.0% | 0.00% | – |
Q1 2015 | $5,000 | +25.0% | 500 | 0.0% | 0.00% | – |
Q4 2014 | $4,000 | – | 500 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
NATIONS FINANCIAL GROUP INC, /IA/ /ADV | 20,150 | $0 | 0.00% |
Advisory Services Network, LLC | 2,233 | $0 | 0.00% |
Fernwood Investment Management, LLC | 34,000 | $0 | 0.00% |